Regulations.gov document
Determination That ATROPINE SULFATE ANSYR PLASTIC SYRINGE (Atropine Sulfate Solution)…
Notice · FDA-2019-P-2123 · posted Sep 24, 2019
Key facts
| Document ID | FDA-2019-P-2123-0003 |
|---|---|
| Title | Determination That ATROPINE SULFATE ANSYR PLASTIC SYRINGE (Atropine Sulfate Solution) Intravenous, Intramuscular, Subcutaneous, and Endotracheal, 0.5 Milligram/5 Milliliters (0.1 Milligram/ Milliliter), Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness |
| Document type | Notice |
| Subtype | Determinations |
| Agency | FDA |
| Docket | FDA-2019-P-2123 |
| Posted | Sep 24, 2019 |
| Federal Register citation | 84 FR 50041 |
| FR document number | 2019-20662 |
| Comment period opens | Sep 24, 2019 |
| Effective date | Sep 24, 2019 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: